NTRB Company Profile and Key Details

Q: Who are the executives of NTRB?

Mr. Gerald GoodmanChief Financial Officer & Chief Accounting OfficerDr. Alan Smith Ph.D.Chief Operating Officer & Pres of 4P TherapeuticsMr. Serguei MelnikFounder, Pres, Company Sec. & Executive ChairmanMr. Gareth SheridanFounder, Chief Executive Officer & DirectorMr. Tyler OverkPres of Active IntelligenceDr. Jeffrey Patrick Pharm.D.Chief Scientific Officer

NASDAQ : NTRB

Nutriband

$3.55

-0.095-2.61%

Open: 11:17 AM

63.66

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Nutriband Inc. (NTRB) stock declined over -2.61%, trading at $3.55 on NASDAQ, down from the previous close of $3.65. The stock opened at $3.61, fluctuating between $3.44 and $3.68 in the recent session.

Stock Snapshot

3.645

Prev. Close

43.15M

Market Cap

3.44

Day Low

-1.38

P/E Ratio

-2.58

EPS (TTM)

-0.46

Cash Flow per Share

3.61

Open

12.16M

Number of Shares

3.68

Day High

49.6%

Free Float in %

0.73

Book Value

1.16K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 28, 2026	3.35	3.69	3.21	3.65	20.3K
May 27, 2026	3.43	3.49	3.40	3.41	5.74K
May 26, 2026	3.55	3.66	3.45	3.49	25.11K
May 22, 2026	3.54	3.64	3.49	3.64	4.94K
May 21, 2026	3.45	3.60	3.42	3.49	9.25K
May 20, 2026	3.54	3.59	3.40	3.53	7.15K
May 19, 2026	3.44	3.46	3.44	3.45	1.48K
May 18, 2026	3.55	3.60	3.42	3.42	19.74K
May 15, 2026	3.51	3.60	3.51	3.60	5.41K
May 14, 2026	3.53	3.59	3.53	3.59	5.66K
May 13, 2026	3.65	3.65	3.50	3.50	2.54K
May 12, 2026	3.60	3.65	3.50	3.65	8.14K
May 11, 2026	3.67	3.70	3.62	3.65	5.64K
May 08, 2026	3.68	3.91	3.68	3.75	17.9K
May 07, 2026	3.92	4.03	3.70	3.79	10.69K
May 06, 2026	4.09	4.18	3.93	3.97	14.17K
May 05, 2026	3.64	4.14	3.64	4.08	32.72K
May 04, 2026	3.89	3.89	3.70	3.70	7.34K
Apr 30, 2026	3.79	3.93	3.75	3.87	5.83K
Apr 29, 2026	3.78	3.86	3.72	3.79	8.73K

Contact Details

Orlando, FL 32801

United States

https://nutriband.com 407 377 6695

About Company

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Stock Peers

ARGX

17.86+2.18%

argenx SE$838.49 REGN

-6.22-0.99%

Regeneron Pharmaceuticals, Inc.$621.52 UTHR

-8.66-1.52%

United Therapeutics Corporation$562.09 MDGL

-11.71-2.22%

Madrigal Pharmaceuticals, Inc.$515.96 VRTX

10.75001+2.46%

Vertex Pharmaceuticals Incorporated$447.97 PRAX

-4.5-1.26%

Praxis Precision Medicines, Inc.$352.63 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

3.67+1.20%

Krystal Biotech, Inc.$310.30 ALNY

9.43+3.19%

Alnylam Pharmaceuticals, Inc.$305.06 ASND

2.21+0.94%

Ascendis Pharma A/S$237.47

Company Overview

Nutriband Inc. (NASDAQ:NTRB) closed at $3.55 USD, losing -$0.10 (-2.61%) from the previous close of $3.65. The stock is currently mid-range between its 52-week high and low $3.21 and $11.68. With a market capitalization of about $43.15 million, Nutriband Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.96). Key stats such as the average daily volume over the past year has been around 11.02 thousand shares, volume is running light vs its 52-week average. Headquartered in Orlando, FL, Nutriband Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Gareth Sheridan, the company employs approximately 13 people and listed since October 01, 2021. Nutriband Inc. develops a portfolio of transdermal pharmaceutical products.

Technical Performance

NTRB has shown mixed momentum, gaining 9.0% over the past week and -38.5% over the past quarter, though year-to-date performance is up 1.32%. Short-term trend indicators are bullishly aligned (SMA20 -1.05%, SMA50 -3.81%, SMA200 -30.92%). The stock’s 14-day RSI is 47.41 (neutral), while the ATR of 0.26 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -63.09% below its high and over 8.84% above its low. Average 10-day trading volume of 10.56 thousand shares is in line with the 3-month average of 11.01 thousand, indicating normal recent market interest.

Valuation Metrics

Nutriband Inc. trades at a P/E ratio of -5.23, slightly below the S&P 500 average, with a price-to-sales ratio of 21.14 and a price-to-book ratio of 6.45 trading at moderately above to book value. The P/FCF stands at -8.4, also below market averages.

Dividend & Fair Value

Nutriband Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.94. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Nutriband Inc. generated EPS of -$3.07 over the past year. Five-year average earnings growth is -18.1%. Nutriband Inc. earnings surprise history is a mixed track record. The quarter that ended April 29, 2026, missed forecasts by -98.94%. The prior quarter beat by -94.37%. Over the last six quarters, Apple has recorded several small beats. These include 50.0% in April 28, 2025.

Shareholding & Insider Activity

Nutriband Inc. has 11.13 million shares outstanding. The public float is 3.10 million shares, elevated short interest at 3.60% of float. This equals 159.02 thousand shares. The short ratio is 0.92 days. Institutional investors hold 13.19% of the float. Insiders own 76.37%.

Financial & Profitability Overview

Over the trailing twelve months, Nutriband generated $2.08M in revenue, or $0.25 per share. Gross margin was 36.08%, operating margin -199.45%, and net profit margin -231.33%. Returns are negative, with ROA at -50.87% and ROE at -56.12%.
On valuation metrics, Nutriband trades at a P/E of -5.23, P/S of 21.14 and P/B of 6.45. The current ratio is 6.36 and quick ratio is 6.21. Operationally, the company’s inventory turnover is 12.96 and cash conversion cycle is 49.39 days. Debt-to-equity is 0.03, supported by a cash flow-to-debt ratio of -24.49.

Quarterly Financial Highlights

For the quarter ended Jan 31, 2023, Nutriband posted revenue of $2.08M, down slightly from $2.08M in the prior quarter. Gross profit was $750.41K (margin 36.08%). Operating income was - $4.15M (margin -199.5%). Net income was- $4.81M (EPS - $0.57).
The company ended the quarter with $1.99M in cash and short-term investments, a total debt of $185.81K, and net debt of - $1.80M. Total assets were $9.46M, with equity of $0.00. Financials further reflected weakness, with operating cash flow of - $2.99M, free cash flow of - $3.07M, and capital expenditures of - $79.30K.

Price Forecast & Outlook

Our AI price prediction model suggests that Nutriband Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.96%, with price expected at $3.25 by June 11, 2026, within a range of $3.10 to $3.41 3-Month Outlook: Projected rise of 19.73%, reaching $4.37 by August 26, 2026, with a range of $3.80 to $4.75. 1-Year Outlook: Projected loss of -15.34%, with price at $3.09 by May 28, 2027, within a range of $0.77 to $2.91.

Key Takeaways

Nutriband Inc. (NASDAQ:NTRB) shares are flat 1.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Nutriband Inc. trading at a premium to the broader market with a P/E of -5.23. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $13.00, suggesting 256.16% upside. Our AI forecast model points to short-term weakness (-10.96% over two weeks), a medium-term rise (19.73% over three months), and a longer-term loss (-15.34% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Nutriband Inc. (NTRB) stock price?

Nutriband Inc. (NASDAQ: NTRB) stock price is $3.55 in the last trading session. During the trading session, NTRB stock reached the peak price of $3.68 while $3.44 was the lowest point it dropped to. The percentage change in NTRB stock occurred in the recent session was -2.61% while the dollar amount for the price change in NTRB stock was - $0.10.

NTRB's industry and sector of operation?

The NASDAQ listed NTRB is part of Biotechnology industry that operates in the broader Healthcare sector. Nutriband Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NTRB?

Mr. Gerald Goodman
Chief Financial Officer & Chief Accounting Officer
Dr. Alan Smith Ph.D.
Chief Operating Officer & Pres of 4P Therapeutics
Mr. Serguei Melnik
Founder, Pres, Company Sec. & Executive Chairman
Mr. Gareth Sheridan
Founder, Chief Executive Officer & Director
Mr. Tyler Overk
Pres of Active Intelligence
Dr. Jeffrey Patrick Pharm.D.
Chief Scientific Officer

How NTRB did perform over past 52-week?

NTRB's closing price is 13.59% higher than its 52-week low of $3.21 where as its distance from 52-week high of $11.68 is -68.79%.

How many employees does NTRB have?

Number of NTRB employees currently stands at 13.

Link for NTRB official website?

Official Website of NTRB is: https://nutriband.com

How do I contact NTRB?

NTRB could be contacted at phone 407 377 6695 and can also be accessed through its website. NTRB operates from 121 South Orange Avenue, Orlando, FL 32801, United States.

How many shares of NTRB are traded daily?

NTRB stock volume for the day was 1.16K shares. The average number of NTRB shares traded daily for last 3 months was 11.02K.

What is the market cap of NTRB currently?

The market value of NTRB currently stands at $43.15M with its latest stock price at $3.55 and 12.16M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	1.88
Sales or Revenue	$2.08M
5Y Sales Change%	5.674%
Fiscal Year Ends	January
Sector	Healthcare
Industry	Biotechnology

NTRB Company Profile and Key Details

Nutriband

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways